Skip to main content
. 2008 Nov 26;12(Suppl 6):S4. doi: 10.1186/cc7027

Figure 2.

Figure 2

28-Day mortality: heparin versus no heparin. Shown are 28-day all-cause mortality rates in patients with or without heparin prophylaxis during the 4-day study drug infusion according to prothrombin fragment (PF)1.2 plasma levels. TFPI, tissue factor pathway inhibitor.